SERUM INSTITUTE OF INDIA
COVID-19 Vaccine Update: SII Begins Manufacturing of Novavax's Protein-Based Vaccine Covovax; To Start Trial in Kids in July
COVID-19 Vaccine Latest Update: Production of First Batch of 'Covovax' Begins at Serum Institute of India Facility
COVID-19 Vaccine in India: Single Dose of Covishield 61% Effective Against Delta Variant, Says Dr NK Arora
Adar Poonawalla Thanks Joe Biden, EAM S Jaishankar for US Policy Change, Says 'COVID-19 Vaccine Production Will Increase'
Serum Institute of India Gets DCGI's Nod to Manufacture COVID-19 Vaccine Sputnik V in India
Covid-19 Vaccine Update: US VP Kamala Harris Calls PM Modi, US To Send 6 Million AstraZeneca Doses; Centre Makes New Vaccine Deal With Biological E; Serum Institute Applies To Produce Sputnik V
Covishield, COVAXIN And Sputnik V Now Available for COVID-19 Vaccination in India; Know Price, Gap Between Doses And Other Details About The Coronavirus Vaccines
COVID-19 Vaccination in India: Centre Creating ‘Artificial Scarcity’ of Coronavirus Vaccines To Benefit Bharat Biotech, Serum Institute', Says AAP Spokesperson Atishi
Pfizer Says Its Coronavirus Vaccine Effective Against B.1.6.1.7 Variant From India, Seeks Fast Track Approval
COVID-19 Vaccine Shortage: Govt Widened Vaccination Drive Without Considering Stock, WHO Guidelines, Says SII Executive Director Suresh Jadhav
COVID-19 Vaccine Shortage: Serum Institute of India CEO Adar Poonawalla Says ‘Vaccination for India’s Large Population Can’t Be Completed Within 2–3 Months’
COVID-19 Vaccine Shortage: Never Exported Vaccines At Cost of People In India, Says Serum Institute of India CEO Adar Poonawalla
Delhi CM Arvind Kejriwal Writes To PM Narendra Modi, Requesting To Allow Other Companies To Manufacture COVID-19 Vaccines
Google Trends